Deutsche Bank’s iTeos Therapeutics ITOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$335K Sell
33,556
-30
-0.1% -$299 ﹤0.01% 2660
2025
Q1
$201K Buy
33,586
+21,055
+168% +$126K ﹤0.01% 2921
2024
Q4
$96.2K Sell
12,531
-14,418
-54% -$111K ﹤0.01% 3254
2024
Q3
$275K Buy
26,949
+5,908
+28% +$60.3K ﹤0.01% 2718
2024
Q2
$312K Sell
21,041
-2,637
-11% -$39.1K ﹤0.01% 2540
2024
Q1
$323K Buy
23,678
+389
+2% +$5.31K ﹤0.01% 2528
2023
Q4
$255K Sell
23,289
-1,342
-5% -$14.7K ﹤0.01% 2697
2023
Q3
$270K Buy
24,631
+2,552
+12% +$27.9K ﹤0.01% 2556
2023
Q2
$292K Sell
22,079
-59,142
-73% -$783K ﹤0.01% 2665
2023
Q1
$1.11M Buy
81,221
+7,216
+10% +$98.2K ﹤0.01% 2034
2022
Q4
$1.45M Buy
74,005
+57,633
+352% +$1.13M ﹤0.01% 1839
2022
Q3
$312K Sell
16,372
-583,459
-97% -$11.1M ﹤0.01% 2655
2022
Q2
$12.4M Sell
599,831
-82,971
-12% -$1.71M 0.01% 925
2022
Q1
$22M Buy
682,802
+670,533
+5,465% +$21.6M 0.01% 814
2021
Q4
$571K Sell
12,269
-57,898
-83% -$2.69M ﹤0.01% 2735
2021
Q3
$1.9M Sell
70,167
-417
-0.6% -$11.3K ﹤0.01% 2135
2021
Q2
$1.81M Sell
70,584
-1,043
-1% -$26.8K ﹤0.01% 2314
2021
Q1
$2.45M Buy
71,627
+63,653
+798% +$2.18M ﹤0.01% 2019
2020
Q4
$270K Buy
7,974
+2,267
+40% +$76.8K ﹤0.01% 3257
2020
Q3
$141K Buy
+5,707
New +$141K ﹤0.01% 3351